These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 34801013)
21. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420 [TBL] [Abstract][Full Text] [Related]
22. Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations. Hernandez L; O'Donnell M; Postma M Pharmacoeconomics; 2018 Oct; 36(10):1223-1252. PubMed ID: 29971666 [TBL] [Abstract][Full Text] [Related]
23. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review. Allen D; Gillen E; Rixson L JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426 [TBL] [Abstract][Full Text] [Related]
24. A protocol for a systematic review of economic evaluation studies conducted on neonatal systemic infections in South Asia. Murthy S; John D; Godinho IP; Godinho MA; Guddattu V; Nair NS Syst Rev; 2017 Dec; 6(1):252. PubMed ID: 29233168 [TBL] [Abstract][Full Text] [Related]
25. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis. Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530 [TBL] [Abstract][Full Text] [Related]
26. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model. Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231 [TBL] [Abstract][Full Text] [Related]
27. Methodological reviews of economic evaluations in health care: what do they target? Hutter MF; Rodríguez-Ibeas R; Antonanzas F Eur J Health Econ; 2014 Nov; 15(8):829-40. PubMed ID: 23974963 [TBL] [Abstract][Full Text] [Related]
28. Economics methods in Cochrane systematic reviews of health promotion and public health related interventions. Shemilt I; Mugford M; Drummond M; Eisenstein E; Mallender J; McDaid D; Vale L; Walker D; BMC Med Res Methodol; 2006 Nov; 6():55. PubMed ID: 17107612 [TBL] [Abstract][Full Text] [Related]
29. Mapping evidence on the distribution of the costs associated with cancer of prostate, cervix, and female breast in the sub-Saharan Africa: protocol for a scoping review. Ngcamphalala C; Ostensson E; Hlongwa M; Ginindza TG Syst Rev; 2021 Apr; 10(1):113. PubMed ID: 33863378 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations. Le LK; Esturas AC; Mihalopoulos C; Chiotelis O; Bucholc J; Chatterton ML; Engel L PLoS Med; 2021 May; 18(5):e1003606. PubMed ID: 33974641 [TBL] [Abstract][Full Text] [Related]
31. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation. Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127 [TBL] [Abstract][Full Text] [Related]
32. Mapping the evidence on health equity considerations in economic evaluations of health interventions: a scoping review protocol. Besar Sa'aid H; Mathew S; Richardson M; Bielecki JM; Sander B Syst Rev; 2020 Jan; 9(1):6. PubMed ID: 31915067 [TBL] [Abstract][Full Text] [Related]
33. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges? Anopa Y; Conway DI Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482 [TBL] [Abstract][Full Text] [Related]
34. Methodological aspects of economic evaluations conducted in the palliative or end of life care settings: a systematic review protocol. Fischer C; Chwala E; Simon J BMJ Open; 2020 May; 10(5):e035760. PubMed ID: 32467253 [TBL] [Abstract][Full Text] [Related]
35. What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations. Long L; Briscoe S; Cooper C; Hyde C; Crathorne L Health Technol Assess; 2015 Jan; 19(8):1-134. PubMed ID: 25629427 [TBL] [Abstract][Full Text] [Related]
36. Systematic reviews of health economic evaluations: A structured analysis of characteristics and methods applied. Luhnen M; Prediger B; Neugebauer EAM; Mathes T Res Synth Methods; 2019 Jun; 10(2):195-206. PubMed ID: 30761762 [TBL] [Abstract][Full Text] [Related]
37. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review. Ashfaq K; Yahaya I; Hyde C; Andronis L; Barton P; Bayliss S; Chen YF Health Technol Assess; 2010 Dec; 14(54):iii-iv, ix-xi, 1-141. PubMed ID: 21138675 [TBL] [Abstract][Full Text] [Related]
38. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA). Brettschneider C; Lühmann D; Raspe H GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289 [TBL] [Abstract][Full Text] [Related]